Abstract:Abstract Digital analysis of pathology whole-slide images is fast becoming a game changer in cancer diagnosis and treatment. Specifically, deep learning methods have shown great potential to support pathology analysis, with recent studies identifying molecular traits that were not previously recognized in pathology H&E whole-slide images. Simultaneous to these developments, it is becoming increasingly evident that tumor heterogeneity is an important determinant of cancer prognosis and susceptibility to treatment, and should therefore play a role in the evolving practices of matching treatment protocols to patients. State of the art diagnostic procedures, however, do not provide automated methods for characterizing and/or quantifying tumor heterogeneity, certainly not in a spatial context. Further, existing methods for analyzing pathology whole-slide images from bulk measurements require many training samples and complex pipelines. Our work addresses these two challenges. First, we train deep learning models to spatially resolve bulk mRNA and miRNA expression levels on pathology whole-slide images (WSIs). Our models reach up to 0.95 AUC on held-out test sets from two cancer cohorts using a simple training pipeline and a small number of training samples. Using the inferred gene expression levels, we further develop a method to spatially characterize tumor heterogeneity. Specifically, we produce tumor molecular cartographies and heterogeneity maps of WSIs and formulate a heterogeneity index (HTI) that quantifies the level of heterogeneity within these maps. Applying our methods to breast and lung cancer slides, we show a significant statistical link between heterogeneity and survival. Our methods potentially open a new and accessible approach to investigating tumor heterogeneity and other spatial molecular properties and their link to clinical characteristics, including treatment susceptibility and survival.

High-dimensional Bayesian Model for Disease-Specific Gene Detection in Spatial Transcriptomics

Bayesian statistics in spatial epidemiology]

Bayesian hidden mark interaction model for detecting spatially variable genes in imaging-based spatially resolved transcriptomics data

A bayesian multivariate mixture model for high throughput spatial transcriptomics

Bayesian modeling of spatial molecular profiling data via Gaussian process

A Bayesian modified Ising model for identifying spatially variable genes from spatial transcriptomics data

A Robust Hybrid Approach Based on Estimation of Distribution Algorithm and Support Vector Machine for Hunting Candidate Disease Genes.

Spanve: an Statistical Method to Detect Clustering-friendly Spatially Variable Genes in Large-scale Spatial Transcriptomics Data

Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer

A Bayesian mark interaction model for analysis of tumor pathology images

An interpretable Bayesian clustering approach with feature selection for analyzing spatially resolved transcriptomics data

Bayesian Flexible Modelling of Spatially Resolved Transcriptomic Data

A Bayesian spatial model for imaging genetics

Joint identification of spatially variable genes via a network-assisted Bayesian regularization approach

A Robust Statistical Approach for Finding Informative Spatially Associated Pathways

Spatially Structured Regression for Non-conformable Spaces: Integrating Pathology Imaging and Genomics Data in Cancer

Latent Space Inference For Spatial Transcriptomics

Joint Bayesian estimation of cell dependence and gene associations in spatially resolved transcriptomic data

Computational Modeling for Deciphering Tissue Microenvironment Heterogeneity from Spatially Resolved Transcriptomics

Generalized Bayesian nonparametric clustering framework for high-dimensional spatial omics data

Spatial transcriptomics at subspot resolution with BayesSpace